Obsessive-Compulsive Disorder Cognitive Behavior Therapy

Abstract

Researchers at University of Pennsylvania School of Medicine, Duke University, Brown, Michigan, and University of Massachusetts, Worcester, as members of the Pediatric-OCD Treatment Study II (POTS II) Randomized Controlled Trial, examined effects of augmenting serotonin reuptake inhibitor (SRI) treatment with short-term cognitive behavior therapy (CBT) in 124 pediatric outpatients, 7 to 17 years of age, with a primary diagnosis of OCD.

Keywords

• serotonin reuptake inhibitor
• cognitive behavior therapy
• medication plus instruction